Clinical Trial: The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional

Official Title: The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

Brief Summary: To find the safe effective lowest light dose for photodynamic therapy (PDT). in the treatment of central serous chorioretinopathy.

Detailed Summary:
Sponsor: Yeungnam University College of Medicine

Current Primary Outcome: Changes of best corrected visual acuity [ Time Frame: 6 month ]

Changes of best corrected visual acuity at baseline and 1, 3, 6 month after PDT


Original Primary Outcome: Same as current

Current Secondary Outcome: Change of central retinal thickness, success rate, recurrence rate, and complications [ Time Frame: 6 months ]

Change of the central retinal thickness on optical coherence tomography (OCT)are compared at baseline at 1, 3, and 6 months after PDT. Additionally, success rate, recurrence rate, and complications between three groups are evaluated during 6 months.


Original Secondary Outcome: Same as current

Information By: Yeungnam University College of Medicine

Dates:
Date Received: June 26, 2012
Date Started: June 2012
Date Completion: March 2015
Last Updated: February 13, 2015
Last Verified: February 2015